American College of Clinical Pharmacy
      Search      Cart
         

SCHEDULE

Critical Care PRN Focus Session — An Analysis of Paralysis: Neuromuscular Blocking Agents in the Critical Care Setting

Tuesday, October 21, 2025 from 10:15 a.m. to 11:45 a.m. CDT at Great Lakes C, 4th Floor

Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-25-132-L01-P
Activity Type: A Knowledge-Based Activity

Neuromuscular blocking agents (NMBAs) have many clinical uses in the critical care setting including rapid sequence intubation (RSI), acute respiratory distress syndrome (ARDS), and various neurologic conditions. Data for the usage, patient populations with which to apply the data, and execution of using these agents requires an intimate understanding of the strengths and limitations of the literature to promote safe and effective therapy. This session will explore some of the clinical controversies surrounding the application of NMBAs to various critically ill patients. The session will be 90 minutes broken down into 3 sections and include interactive patient cases as the backdrop for each subsection. The first section will explore RSI, investigate the evidence of rocuronium versus succinylcholine, and the considerations surrounding early continuous sedation after RSI. The second section will explore the mechanism of usage of NMBA, specifically investigating continuous versus intermittent NMBA and goals of therapeutic “monitoring” for NMBAs (e.g., train-of-four versus ventilator targets versus bispectral index monitoring). The final section will explore the use of NMBAs without sedation for various diagnostic and therapeutic applications (e.g., somatosensory evoked potentials (SSEPs) testing) and investigate the use of sugammadex for NMBA reversal in non-operating room settings.

Learning Objectives

1. Summarize the data for the use of rocuronium versus succinylcholine to facilitate RSI.

2. Define effective sedation strategies after RSI to prevent awake paralysis.

3. List the pharmacologic advantages and disadvantages of continuous versus intermittent NMBA for various clinical scenarios.

4. Discuss the monitoring of clinical endpoints when using NMBA for various clinical scenarios.

5. Explain sedation practices and unique considerations for the use of awake paralysis while utilizing NMBAs.

6. Identify opportunities for NMBA reversal optimization outside of the operating room.

Scott T. Benken, Pharm.D., MHPE, FCCP, FCCM, BCCCP
Moderator:Scott T. Benken, Pharm.D., MHPE, FCCP, FCCM, BCCCP
Clinical Associate Professor | Pharmacy Practice | Retzky College of Pharmacy
Clinical Pharmacist | Medical Intensive Care Unit | University of Illinois Health
PGY2 Critical Care Pharmacy Residency - Program Director
  View Biography

An Analysis of Paralysis: Focus on NMBA in RSI

10:15 a.m. to 10:45 a.m.
Megan A. Rech, Pharm.D., Masters in Research, FCCP, FCCM, BCCCP
Speaker:Megan A. Rech, Pharm.D., Masters in Research, FCCP, FCCM, BCCCP
Research Health Scientist | Clinical Pharmacist Specialist
Center of Innovation for Complex Chronic Healthcare
Edward Hines Jr VA Hospital
  View Biography

An Analysis of Paralysis: Focus on NMBA Administration and Monitoring

10:45 a.m. to 11:15 a.m.
Julie DiBridge Clarkson, Pharm.D., BCCCP, BCCP
Speaker:Julie DiBridge Clarkson, Pharm.D., BCCCP, BCCP
Assistant Professor, University of Pittsburgh School of Pharmacy
Clinical Pharmacist, Advanced Heart Failure and Pulmonary Hypertension, UPMC Presbyterian Hospital
Pittsburgh, PA
  View Biography

An Analysis of Paralysis: Focus on NMBA and Awake Paralysis and Reversal Strategies

11:15 a.m. to 11:45 a.m.
Eric Johnson, Pharm.D., MBA, BCCCP
Speaker:Eric Johnson, Pharm.D., MBA, BCCCP
Perioperative Critical Care Pharmacist
University of Kentucky HealthCare
Associate Adjunct Professor | UK Colleges of Pharmacy and Medicine
Department of Pharmacy Practice and Science
Department of Anesthesiology, Perioperative, Critical Care & Pain Medicine
Lexington, Kentucky
  View Biography

Cookies

This website uses cookies to help ACCP provide you with the best user experience. If you continue to use our services, ACCP will assume that you agree to the use of such cookies. You can find out how to update your settings by referring to ACCP’s Policy on Cookies.